FDA inspection
AstraZeneca AB: FDA inspection ending Jan 27, 2017
FDA inspection 1007887 · No Action Indicated (NAI) · Sodertalje
Key facts
| Inspection ID | 1007887 |
|---|---|
| Firm | AstraZeneca AB |
| FEI number | 3003342394 |
| Address | Gartunavagen, SE-152 57 |
| City | Sodertalje |
| Country | Sweden |
| Fiscal year | 2017 |
| Inspection end date | Jan 27, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data